Literature DB >> 12133978

Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10.

Kaan Boztug1, Monica J Carson, Ngan Pham-Mitchell, Valérie C Asensio, Julie DeMartino, Iain L Campbell.   

Abstract

The CXC chemokine ligand (CXCL)10 is induced locally in the CNS in diverse pathologic states. The impact of CXCL10 production in the CNS was examined in transgenic mice with astrocyte-directed production of this chemokine. These glial fibrillary acidic protein (GF)-CXCL10 transgenic mice spontaneously developed transgene dose- and age-related leukocyte infiltrates in perivascular, meningeal, and ventricular regions of the brain that were composed of, surprisingly, mainly neutrophils and, to a lesser extent, T cells. No other overt pathologic or physical changes were evident. In addition, the cerebral expression of a number of inflammation-related genes (e.g., cytokines) was not significantly altered in the transgenic mice. The extent of leukocyte recruitment to the brain could be enhanced markedly by peripheral immunization of GF-CXCL10 mice with CFA and pertussis toxin. This was paralleled by a modest, transient increase in the expression of some cytokine and chemokine genes. Analysis of the expression of the CXCL10 receptor, CXCR3, by the brain-infiltrating leukocytes from immunized GF-CXCL10 transgenic mice revealed a significant enrichment for CXCR3-positive cells in the CNS compared with spleen. The majority of cells positive for CXCR3 coexpressed CD3, whereas Gr1-positive granulocytes were negative for CXCR3 expression. Thus, while astrocyte production of CXCL10 can promote spontaneous and potentiate immune-induced recruitment of leukocytes to the CNS, this is not associated with activation of a degenerative immune pathology. Finally, the accumulation of neutrophils in the brain of GF-CXCL10 transgenic mice is apparently independent of CXCR3 and involves an unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133978     DOI: 10.4049/jimmunol.169.3.1505

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

2.  Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.

Authors:  G E Serrano; N Lelutiu; A Rojas; S Cochi; R Shaw; C D Makinson; D Wang; G A FitzGerald; R Dingledine
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

3.  CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model.

Authors:  Louisa Nitsch; Julian Zimmermann; Marius Krauthausen; Markus J Hofer; Raman Saggu; Gabor C Petzold; Michael T Heneka; Daniel R Getts; Albert Becker; Iain L Campbell; Marcus Müller
Journal:  Mol Neurobiol       Date:  2019-06-02       Impact factor: 5.590

4.  Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury.

Authors:  T Bucky Jones; Ronald P Hart; Phillip G Popovich
Journal:  J Neurosci       Date:  2005-07-13       Impact factor: 6.167

5.  Opposing roles for CXCR3 signaling in central nervous system versus ocular inflammation mediated by the astrocyte-targeted production of IL-12.

Authors:  Marius Krauthausen; Sally L Ellis; Julian Zimmermann; Maria Sarris; Denis Wakefield; Michael T Heneka; Iain L Campbell; Marcus Müller
Journal:  Am J Pathol       Date:  2011-09-15       Impact factor: 4.307

6.  The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.

Authors:  Markus J Hofer; Wen Li; Sue Ling Lim; Iain L Campbell
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

7.  Borna disease virus multiplication in mouse organotypic slice cultures is site-specifically inhibited by gamma interferon but not by interleukin-12.

Authors:  Gregor Friedl; Markus Hofer; Bernd Auber; Christian Sauder; Jürgen Hausmann; Peter Staeheli; Axel Pagenstecher
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period.

Authors:  Ralph Feuer; Chelsea M Ruller; Naili An; Jenna M Tabor-Godwin; Ross E Rhoades; Sonia Maciejewski; Robb R Pagarigan; Christopher T Cornell; Stephen J Crocker; William B Kiosses; Ngan Pham-Mitchell; Iain L Campbell; J Lindsay Whitton
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

9.  Consequences of CXCL10 and IL-6 induction by the murine IFN-alpha1 transgene in ocular herpes simplex virus type 1 infection.

Authors:  Stephanie Wickham; John Ash; Thomas E Lane; Daniel J J Carr
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 10.  Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases.

Authors:  Egle Cekanaviciute; Marion S Buckwalter
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.